impact factor, citescore
logo
 

Full Papers

 

Clinical features and independent predictors of Behçet’s disease associated with myelodysplastic syndrome


1, 2, 3, 4, 5, 6, 7, 8

 

  1. Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  2. Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  3. Department of Haematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  4. Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  5. Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  6. Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  7. Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. fccliusy2@zzu.edu.cn
  8. Department of Rheumatology and Immunology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. tfli@zzu.edu.cn

CER16135
2023 Vol.41, N°9
PI 1823, PF 1830
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 36762734 [PubMed]

Received: 15/08/2022
Accepted : 05/01/2023
In Press: 07/02/2023
Published: 17/08/2023

Abstract

OBJECTIVES:
To investigate the correlation of Behçet’s disease (BD) with myelodysplastic syndrome (MDS) and identify the predictive risk factors in Chinese patients.
METHODS:
A retrospective study of BD associated with MDS (BD-MDS) patients from the First Affiliated Hospital of Zhengzhou University was conducted.
RESULTS:
Among 15 BD-MDS patients, 10 were females and 5 males. While 13 (86.7%) patients had abnormal karyotype, 11 patients with trisomy 8. 10 (66.7%) had gastrointestinal (GI) involvement. Compared with 60 general BD patients without MDS, the BD-MDS patients were significantly older. In addition, fever and GI involvement were more common in BD-MDS patients, whereas these patients had lower levels of leukocyte count, haemoglobin, and platelet count (p<0.05). Logistic regression analysis showed that GI involvement, low haemoglobin, and high ESR level were independently associated with the development of MDS in BD patients. BD-MDS patients with GI involvement (IBD-MDS) were usually much older and have more fever than IBD patients without MDS, as well as lower leukocyte count, haemoglobin level, platelet count, and higher erythrocyte sedimentation rate (ESR) and C-reactive protein levels (p<0.05). By comparison with 60 primary MDS patients without BD, the BD-MDS patients had more abnormal karyotypes and more trisomy 8 (p<0.05), while the distribution of 2016 WHO subtypes of MDS and IPSS-R categories were similar.
CONCLUSIONS:
Our findings suggest that cytogenetic abnormalities, especially trisomy 8, may play a role in the association of GI involvement, BD, and MDS. GI involvement, low haemoglobin, and high ESR level were independent predictors for MDS development in BD patients.

DOI: https://doi.org/10.55563/clinexprheumatol/04us5e

Rheumatology Article